Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alopecia
Fierce Pharma
Veradermics grows hair loss med hopes on $150M funding wave
Veradermics will use the funding to support further phase 3 development for its extended-release formulation of oral minoxidil.
Zoey Becker
Oct 16, 2025 7:30am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
HCW Biologics clings on with $5M lifeline to fund alopecia trial
May 16, 2025 7:00am
Q32 Bio sticks with bempikibart but lets go of staff
Feb 11, 2025 4:47am
Q32's stock plunges in wake of anti-IL-7R antibody's eczema fail
Dec 11, 2024 8:25am
Soterios looks to ph. 3 after win for alopecia areata cream
May 30, 2024 8:14am